Loffroy Romaric, Guiu Boris, Cercueil Jean-Pierre, Krausé Denis
University of Dijon School of Medicine, Bocage Teaching Hospital, Dijon, France.
Abdom Imaging. 2010 Jun;35(3):306-14. doi: 10.1007/s00261-009-9515-x. Epub 2009 Apr 16.
Chronic mesenteric ischemia is a rare condition caused by occlusive disease of the mesenteric vessels and manifested most commonly as abdominal pain. While the traditional therapy in symptomatic patients has been surgery, recent improvements in interventional devices and refinement in techniques have increased the popularity of endovascular treatment. The high procedural success and the low complication rate make the catheter-based approach an interesting alternative to surgery. Percutaneous angioplasty and stenting is now recognized as a minimally invasive means of obtaining good long-term results and is consequently suggested for the primary treatment of chronic mesenteric ischemia. This article presents a review of the literature on indications and technical aspects of endovascular treatment, with emphasis on short- and long-term outcomes.
慢性肠系膜缺血是一种由肠系膜血管闭塞性疾病引起的罕见病症，最常见的表现为腹痛。虽然有症状患者的传统治疗方法是手术，但近年来介入设备的改进和技术的精细化提高了血管内治疗的普及程度。高手术成功率和低并发症发生率使基于导管的治疗方法成为手术的一个有吸引力的替代方案。经皮血管成形术和支架置入术现在被认为是一种能取得良好长期效果的微创手段，因此建议用于慢性肠系膜缺血的初始治疗。本文综述了血管内治疗的适应证和技术方面的文献，重点关注短期和长期疗效。
